Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017
Open Access
- 1 May 2020
- journal article
- research article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 26 (5), 902-909
- https://doi.org/10.3201/eid2605.190556
Abstract
P. falciparum Drug-Resistance Alleles, HaitiKeywords
This publication has 44 references indexed in Scilit:
- Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2017
- Population genetic structure and adaptation of malaria parasites on the edge of endemic distributionMolecular Ecology, 2017
- Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised TrialPLoS Medicine, 2016
- Cost-effectiveness of seasonal malaria chemoprevention in upper west region of GhanaMalaria Journal, 2016
- Malaria treatment policies and drug efficacy in Haiti from 1955-2012Journal of Pharmaceutical Policy and Practice, 2013
- A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malariaMalaria Journal, 2009
- Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine–pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparumInfection, Genetics and Evolution, 2007
- A Molecular Marker for Chloroquine-Resistant Falciparum MalariaThe New England Journal of Medicine, 2001
- Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.1984